In this issue of BETA, readers will find a feature article sorting out studies of structured treatment interruptions, as well as an overview of the current wave of methamphetamine use and what HIV positive people should know about meth. Liz Highleyman untangles the complex subject of switching antiretroviral regimens. And, as always, the "News Briefs" column highlights recent HIV/AIDS related developments at medical conferences and elsewhere, and the "Open Clinical Trials" column lists important opportunities for readers to participate in the development of new treatments for HIV and HIV-related conditions.
Also in this issue, members of BETA's Scientific Advisory Committee reflect on the past 25 years of HIV and AIDS, and on the future. As the new editor of BETA, I am mindful of the years of personal experience, activism, and research that form the foundation of this treatment education magazine, and I look forward to providing the accurate, thorough, and accessible HIV health information that readers expect from BETA.
Back to the SFAF BETA Summer 2006 contents page.
This article was provided by San Francisco AIDS Foundation. It is a part of the publication Bulletin of Experimental Treatments for AIDS. Visit San Francisco AIDS Foundation's Web site to find out more about their activities, publications and services.